Modulation of amphetamine-stimulated (transporter mediated) dopamine release in vitro by σ2 receptor agonists and antagonists

European Journal of Pharmacology

Volumn 346, Issue 2-3, 1998, Pages 189-196

  Izenwasser, Sari ^a   Thompson Montgomery, DeDeene ^b   Deben, Sophia E ^b   Chowdhury, Iffat N ^b   Werling, Linda L ^b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Caudate putamen; Cocaine; Dopamine transporter; Dopamine uptake

Indexed keywords

1 CYCLOPROPYLMETHYL 4 [2 (4 FLUOROPHENYL) 2 OXOETHYL]PIPERIDINE; 2,3 DIHYDRO 3 ISOPROPYL 2 OXO 1 BENZIMIDAZOLECARBOXYLIC ACID 3ALPHA TROPANYLAMIDE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE; N [1,2 [2 (3,4 DICHLOROPHENYL)ETHYL]] N METHYL 2 (1 PYRROLIDINYL)CYCLOHEXYLAMINE; N [2 (3,4 DICHLOROPHENYL)ETHYL] N METHYL 2 (1 PYRROLIDINYL)ETHYLAMINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CAUDATE NUCLEUS; DOPAMINE RELEASE; DOPAMINE UPTAKE; DRUG ABUSE; DRUG EFFECT; DRUG RECEPTOR BINDING; IN VITRO STUDY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT;

AMPHETAMINE; ANALGESICS; ANIMALS; CALCIUM; CARRIER PROTEINS; CYCLOHEXYLAMINES; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; MAGNESIUM; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NARCOTICS; NERVE TISSUE PROTEINS; PENTAZOCINE; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SIGMA;

EID: 0032502638     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00063-6     Document Type: Article

References (39)

1. 2 binding site in guinea pig hippocampus. J. Pharmacol. Exp. Ther. 267:1993;961-970.
2. Bowen W.D., Vilner B.J., Lee K.S., He X.-S., deCosta B.R., Weinberger D.R. A haloperidol-insensitive binding site for sigma-active aryl ethylene diamine-related compounds: A novel σ receptor subtype? Soc. Neurosci. Abst. 21:1995;526.
3. Carroll F.I., Abraham P., Parham K., Bai X., Zhang Z., Brine G.A., Mascarella S.W., Martin B.R., May E.L., Sauss C., DiPaolo L., Wallace P., Walker J.M., Bowen W.D. Enantiomeric N-substituted n-normetazocines: a comparative study of affinities at σ, PCP, and μ opioid receptors. J. Med. Chem. 35:1992;2812-2818.
4. 2 receptors can modulate dopamine uptake. Neurosci. Lett. 176:1994;259-263.
5. 2 receptor in rat brain. Mol. Pharmacol. 42:1992;471-479.
6. 3H]DuP734 [1-(cyclopropylmethyl]-4-(2′4″-flourophenyl)-2′-oxoethyl)piper idine HBr]: A receptor binding profile of a high affinity novel σ receptor ligand in guinea pig brain. J. Pharmacol. Exp. Ther. 263:1992;1175-1187.
7. 3H](+)-pentazocine, a highly potent and selective radioligand for σ receptors. FEBS Lett. 251:1989;53-58.
8. 2 receptor. Life Sci. 45:1989;401-411.
9. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
10. Gonzalez A., Werling L.L. Sigma receptor regulation of norepinephrine release from rat hippocampal slices. Brain Res. 673:1995;61-69.
11. 3H]dopamine release from rat striatal slices by σ receptor ligands. J. Pharmacol. Exp. Ther. 271:1994;212-219.
12. 3H]dopamine release via a presynaptic mechanism. Eur. J. Pharmacol. 294:1995;713-719.
13. Hellewell S.B., Bowen W.D. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor from that of guinea pig brain. Brain Res. 527:1990;244-253.
14. 3H]dopamine release in rat striatum. J. Neurochem. 56:1991;603-610.
15. Izenwasser S., Newman A.H., Katz J.L. Cocaine and several sigma receptor ligands inhibit dopamine uptake in rat caudate-putamen. Eur. J. Pharmacol. 243:1993;201-205.
16. 3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: A comparison with release elicited by potassium, N-methyl-D-aspartic acid and D-amphetamine. J. Pharmacol. Exp. Ther. 262:1992;356-364.
17. Liang N.Y., Rutledge C.O. Evidence for carrier-mediated efflux of dopamine from corpus striatum. Biochem. Pharmacol. 31:1982;2484-2497.
18. 3H]SKF-10,047 binding sites (σ sites) exhibit a unique distribution in rat brain subcellular fractions. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 188:1990;211-218.
19. McElvain J.S., Schenk J.O. Blockade of dopamine autoreceptors by haloperidol and the apparent dynamics of potassium-stimulated endogenous release of dopamine from and reuptake into striatal suspensions in the rat. Neuropharmacology. 31:1992;649-659.
20. 2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J. Neurochem. 61:1993;764-767.
21. 2 binding site 2. Spiro-joined benzofuran, isobenzofuran, and benzopyran piperidines. J. Med. Chem. 38:1995;2009-2017.
22. 3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc. Natl. Acad. Sci. USA. 92:1995;3774-3778.
23. 3H]noradrenaline release in rat hippocampal slices. Br. J. Pharmacol. 119:1996;65-72.
24. 3 sites in rodent brain. Soc. Neurosci. Abst. 21:1995;1610.
25. 2 binding site 1. 3-(ω-aminoalkyl)-1H-indoles. J. Med. Chem. 38:1995;1998-2007.
26. Quirion R., Bowen W.D., Itzhak Y., Junien J.L., Musacchio J.M., Rothman R.B., Su T.-P., Tam S.W., Taylor D.P. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13:1992;85-86.
27. 3H]SKF 10,047 binding sites in rat liver. Eur. J. Pharmacol. Mol. Pharmacol. Sec. 225:1992;69-74.
28. Schuldiner S., Steiner-Mordoch S., Yelin R., Wall S.C., Rudnick G. Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters. J. Pharmacol. Exp. Ther. 44:1993;1227-1231.
29. Sharkey J., Glen K.A., Wolfe S., Kuhar M.J. Cocaine binding at sigma receptors. Eur. J. Pharmacol. 149:1988;171-174.
30. 3H]SKF-10047 to etorphine-inaccessible sites in guinea pig brain. J. Pharmacol. Exp. Ther. 223:1982;284-290.
31. Sulzer D., Maidment N.T., Rayport S. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J. Neurochem. 60:1993;527-535.
32. Sulzer D., Chen T.-K., Lau Y.Y., Kristensen H., Rayport S., Ewing A. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15:1995;4102-4108.
33. Vilner B.J., Bowen W.D. Dual modulation of cellular calcium by sigma receptor ligands: release from intracellular stores and blockade of voltage-dependent influx. Soc. Neurosci. Abstr. 21:1995;1608.
34. Walker J.M., Bowen W.D., Walker F.O., Matsumoto R.R., Costa B.D., Rice K.C. Sigma receptors: biology and function. Pharmacol. Rev. 42:1990;355-402.
35. 3H]dopamine release from mesolimbic and mesocortical areas of guinea pig brain by sigma receptors. Schizophr. Res. 21:1996;51-62.
36. Werling L.L., Frattali A., Portoghese P.S., Takemori A.E., Cox B.M. Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. J. Pharmacol. Exp. Ther. 246:1988;282-286.
37. Woodward J.J., Harms J. The putative polyamine antagonists ifenprodil and SL 82.0715 enhance dopamine efflux from rat striatal slices independent of NMDA receptor activation. Eur. J. Pharmacol. 210:1992;265-270.
38. Yamashita H., Kitayam S., Zhang Y.-X., Takahashi T., Dohi T., Nakamura S. Effect of nicotine on dopamine uptake in COS cells possessing the rat dopamine transporter and in PC12 cells. Biochem. Pharmacol. 49:1995;742-745.
39. Zhou G.-Z., Musacchio J.M. Computer-assisted modeling of multiple dextromethorphan and sigma binding sites in guinea pig brain. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 206:1991;261-269.